SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001493152-22-036858 from Indaptus Therapeutics, Inc. (INDP)

Indaptus Therapeutics, Inc.
Date: Dec. 30, 2022 · CIK: 0001857044 · Accession: 0001493152-22-036858

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-269000

Date
Dec. 30, 2022
Author
Chief
Form
CORRESP
Company
Indaptus Therapeutics, Inc.

Letter

Indaptus Therapeutics, Inc.

Columbus Circle

15th Floor

New York, New York 10019

December 30, 2022

Securities and Exchange Commission

Division of Corporation Finance

F Street, N.E.

Washington, D.C. 20549

Re: Indaptus Therapeutics, Inc.

Registration Statement on Form S-1

File No. 333-269000

VIA EDGAR

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, Indaptus Therapeutics, Inc. (the “Registrant”) hereby respectfully requests that the effectiveness of the Registration Statement on Form S-1 (File No. 333-269000) of the Registrant (the “Registration Statement”) be accelerated so that the Company’s Registration Statement will be declared effective at 4.30 p.m., Eastern Time, on December 30, 2022, or as soon thereafter as may be practicable.

The undersigned respectfully requests that it be notified of the effectiveness of the Registration Statement by telephone call to our counsel, Greenberg Traurig, P.A., by calling Eyal Peled at (212) 801 9210. The Company hereby authorizes Mr. Peled to orally modify or withdraw this request for acceleration.

Very
truly yours,
INDAPTUS
THERAPEUTICS, INC.

Show Raw Text
CORRESP
1
filename1.htm

Indaptus
Therapeutics, Inc.

3
Columbus Circle

15th
Floor

New
York, New York 10019

December
30, 2022

Securities
and Exchange Commission

Division
of Corporation Finance

100
F Street, N.E.

Washington,
D.C. 20549

    Re:
    Indaptus
    Therapeutics, Inc.

    Registration
    Statement on Form S-1

    File No. 333-269000

VIA
EDGAR

Ladies
and Gentlemen:

Pursuant
to Rule 461 under the Securities Act of 1933, as amended, Indaptus Therapeutics, Inc. (the “Registrant”) hereby respectfully
requests that the effectiveness of the Registration Statement on Form S-1 (File No. 333-269000) of the Registrant (the “Registration
Statement”) be accelerated so that the Company’s Registration Statement will be declared effective at 4.30 p.m., Eastern
Time, on December 30, 2022, or as soon thereafter as may be practicable.

The
undersigned respectfully requests that it be notified of the effectiveness of the Registration Statement by telephone call to our counsel,
Greenberg Traurig, P.A., by calling Eyal Peled at (212) 801 9210. The Company hereby authorizes Mr. Peled to orally modify or withdraw
this request for acceleration.

    Very
    truly yours,

    INDAPTUS
    THERAPEUTICS, INC.

    By:
    /s/
    Nir Sassi

    Name:
    Nir
    Sassi

    Title:
    Chief
    Financial Officer

    cc:
    Gary
    Emmanuel (Greenberg Traurig, P.A.)